nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—SLC22A1—prostate cancer	0.281	0.61	CbGaD
Acebutolol—ADRB2—prostate cancer	0.179	0.389	CbGaD
Acebutolol—SLC22A1—Estradiol—prostate cancer	0.0463	0.147	CbGbCtD
Acebutolol—CYP2D6—Bicalutamide—prostate cancer	0.0388	0.123	CbGbCtD
Acebutolol—ABCB1—Estramustine—prostate cancer	0.0383	0.122	CbGbCtD
Acebutolol—CYP2D6—Abiraterone—prostate cancer	0.0322	0.102	CbGbCtD
Acebutolol—ABCB1—Cabazitaxel—prostate cancer	0.0252	0.0802	CbGbCtD
Acebutolol—ABCB1—Estrone—prostate cancer	0.0247	0.0784	CbGbCtD
Acebutolol—ABCB1—Ethinyl Estradiol—prostate cancer	0.022	0.0699	CbGbCtD
Acebutolol—ABCB1—Conjugated Estrogens—prostate cancer	0.0161	0.0513	CbGbCtD
Acebutolol—ABCB1—Mitoxantrone—prostate cancer	0.0147	0.0466	CbGbCtD
Acebutolol—ABCB1—Estradiol—prostate cancer	0.0142	0.045	CbGbCtD
Acebutolol—ABCB1—Prednisone—prostate cancer	0.0122	0.0387	CbGbCtD
Acebutolol—ABCB1—Etoposide—prostate cancer	0.00925	0.0294	CbGbCtD
Acebutolol—ABCB1—Docetaxel—prostate cancer	0.00847	0.0269	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—prostate cancer	0.00631	0.0201	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—prostate cancer	0.00595	0.0189	CbGbCtD
Acebutolol—Metipranolol—ADRB2—prostate cancer	0.000416	0.122	CrCbGaD
Acebutolol—Esmolol—ADRB2—prostate cancer	0.000331	0.097	CrCbGaD
Acebutolol—Betaxolol—ADRB2—prostate cancer	0.000291	0.0854	CrCbGaD
Acebutolol—Atenolol—ADRB2—prostate cancer	0.000288	0.0847	CrCbGaD
Acebutolol—Bisoprolol—ADRB2—prostate cancer	0.000281	0.0825	CrCbGaD
Acebutolol—Oxprenolol—ADRB2—prostate cancer	0.000264	0.0776	CrCbGaD
Acebutolol—Alprenolol—ADRB2—prostate cancer	0.000242	0.0709	CrCbGaD
Acebutolol—Metoprolol—ADRB2—prostate cancer	0.000225	0.066	CrCbGaD
Acebutolol—Pindolol—ADRB2—prostate cancer	0.000208	0.061	CrCbGaD
Acebutolol—Metoprolol—CYP2C19—prostate cancer	0.000193	0.0568	CrCbGaD
Acebutolol—Bisoprolol—CYP3A4—prostate cancer	0.000154	0.0452	CrCbGaD
Acebutolol—Propranolol—CYP3A5—prostate cancer	0.000143	0.0421	CrCbGaD
Acebutolol—Propranolol—ADRB2—prostate cancer	0.000113	0.0333	CrCbGaD
Acebutolol—Propranolol—CYP2C19—prostate cancer	9.77e-05	0.0287	CrCbGaD
Acebutolol—Propranolol—CYP1A1—prostate cancer	9.73e-05	0.0286	CrCbGaD
Acebutolol—Propranolol—CYP3A4—prostate cancer	6.21e-05	0.0182	CrCbGaD
Acebutolol—Diarrhoea—Mitoxantrone—prostate cancer	6.14e-05	0.000362	CcSEcCtD
Acebutolol—Vomiting—Estradiol—prostate cancer	6.12e-05	0.000361	CcSEcCtD
Acebutolol—Agranulocytosis—Epirubicin—prostate cancer	6.12e-05	0.000361	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—prostate cancer	6.1e-05	0.00036	CcSEcCtD
Acebutolol—Gastrointestinal pain—Etoposide—prostate cancer	6.1e-05	0.00036	CcSEcCtD
Acebutolol—Shock—Docetaxel—prostate cancer	6.1e-05	0.00036	CcSEcCtD
Acebutolol—Nervous system disorder—Docetaxel—prostate cancer	6.08e-05	0.000359	CcSEcCtD
Acebutolol—Ill-defined disorder—Prednisone—prostate cancer	6.08e-05	0.000359	CcSEcCtD
Acebutolol—Rash—Estradiol—prostate cancer	6.07e-05	0.000358	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—prostate cancer	6.07e-05	0.000358	CcSEcCtD
Acebutolol—Dermatitis—Estradiol—prostate cancer	6.06e-05	0.000358	CcSEcCtD
Acebutolol—Confusional state—Capecitabine—prostate cancer	6.05e-05	0.000357	CcSEcCtD
Acebutolol—Headache—Estradiol—prostate cancer	6.03e-05	0.000356	CcSEcCtD
Acebutolol—Skin disorder—Docetaxel—prostate cancer	6.02e-05	0.000355	CcSEcCtD
Acebutolol—Oedema—Capecitabine—prostate cancer	6e-05	0.000354	CcSEcCtD
Acebutolol—Bradycardia—Epirubicin—prostate cancer	5.99e-05	0.000354	CcSEcCtD
Acebutolol—Urticaria—Etoposide—prostate cancer	5.93e-05	0.00035	CcSEcCtD
Acebutolol—Anorexia—Docetaxel—prostate cancer	5.91e-05	0.000349	CcSEcCtD
Acebutolol—Malaise—Prednisone—prostate cancer	5.91e-05	0.000349	CcSEcCtD
Acebutolol—Shock—Capecitabine—prostate cancer	5.91e-05	0.000348	CcSEcCtD
Acebutolol—Rhinitis—Epirubicin—prostate cancer	5.9e-05	0.000348	CcSEcCtD
Acebutolol—Body temperature increased—Etoposide—prostate cancer	5.9e-05	0.000348	CcSEcCtD
Acebutolol—Abdominal pain—Etoposide—prostate cancer	5.9e-05	0.000348	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—prostate cancer	5.9e-05	0.000348	CcSEcCtD
Acebutolol—Nervous system disorder—Capecitabine—prostate cancer	5.89e-05	0.000347	CcSEcCtD
Acebutolol—Vertigo—Prednisone—prostate cancer	5.89e-05	0.000347	CcSEcCtD
Acebutolol—Syncope—Prednisone—prostate cancer	5.87e-05	0.000347	CcSEcCtD
Acebutolol—Hypoaesthesia—Epirubicin—prostate cancer	5.86e-05	0.000346	CcSEcCtD
Acebutolol—Pharyngitis—Epirubicin—prostate cancer	5.84e-05	0.000345	CcSEcCtD
Acebutolol—Skin disorder—Capecitabine—prostate cancer	5.83e-05	0.000344	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—prostate cancer	5.82e-05	0.000343	CcSEcCtD
Acebutolol—Hyperhidrosis—Capecitabine—prostate cancer	5.8e-05	0.000342	CcSEcCtD
Acebutolol—Hypotension—Docetaxel—prostate cancer	5.79e-05	0.000342	CcSEcCtD
Acebutolol—Connective tissue disorder—Epirubicin—prostate cancer	5.78e-05	0.000341	CcSEcCtD
Acebutolol—Loss of consciousness—Prednisone—prostate cancer	5.76e-05	0.00034	CcSEcCtD
Acebutolol—Anorexia—Capecitabine—prostate cancer	5.72e-05	0.000338	CcSEcCtD
Acebutolol—Nausea—Estradiol—prostate cancer	5.72e-05	0.000337	CcSEcCtD
Acebutolol—Vomiting—Mitoxantrone—prostate cancer	5.7e-05	0.000336	CcSEcCtD
Acebutolol—Visual impairment—Epirubicin—prostate cancer	5.67e-05	0.000335	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—prostate cancer	5.66e-05	0.000334	CcSEcCtD
Acebutolol—Rash—Mitoxantrone—prostate cancer	5.65e-05	0.000334	CcSEcCtD
Acebutolol—Dermatitis—Mitoxantrone—prostate cancer	5.65e-05	0.000333	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.65e-05	0.000333	CcSEcCtD
Acebutolol—Headache—Mitoxantrone—prostate cancer	5.62e-05	0.000331	CcSEcCtD
Acebutolol—Hypotension—Capecitabine—prostate cancer	5.61e-05	0.000331	CcSEcCtD
Acebutolol—Insomnia—Docetaxel—prostate cancer	5.61e-05	0.000331	CcSEcCtD
Acebutolol—Arthralgia—Prednisone—prostate cancer	5.58e-05	0.000329	CcSEcCtD
Acebutolol—Myalgia—Prednisone—prostate cancer	5.58e-05	0.000329	CcSEcCtD
Acebutolol—Paraesthesia—Docetaxel—prostate cancer	5.57e-05	0.000328	CcSEcCtD
Acebutolol—Anxiety—Prednisone—prostate cancer	5.56e-05	0.000328	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—prostate cancer	5.54e-05	0.000327	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	5.54e-05	0.000327	CcSEcCtD
Acebutolol—Dyspnoea—Docetaxel—prostate cancer	5.53e-05	0.000326	CcSEcCtD
Acebutolol—Somnolence—Docetaxel—prostate cancer	5.51e-05	0.000325	CcSEcCtD
Acebutolol—Discomfort—Prednisone—prostate cancer	5.51e-05	0.000325	CcSEcCtD
Acebutolol—Tinnitus—Epirubicin—prostate cancer	5.49e-05	0.000324	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.47e-05	0.000323	CcSEcCtD
Acebutolol—Flushing—Epirubicin—prostate cancer	5.46e-05	0.000322	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—prostate cancer	5.46e-05	0.000322	CcSEcCtD
Acebutolol—Dyspepsia—Docetaxel—prostate cancer	5.46e-05	0.000322	CcSEcCtD
Acebutolol—Insomnia—Capecitabine—prostate cancer	5.43e-05	0.00032	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—prostate cancer	5.42e-05	0.00032	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—prostate cancer	5.4e-05	0.000319	CcSEcCtD
Acebutolol—Paraesthesia—Capecitabine—prostate cancer	5.39e-05	0.000318	CcSEcCtD
Acebutolol—Decreased appetite—Docetaxel—prostate cancer	5.39e-05	0.000318	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Docetaxel—prostate cancer	5.35e-05	0.000316	CcSEcCtD
Acebutolol—Asthenia—Etoposide—prostate cancer	5.35e-05	0.000316	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—prostate cancer	5.35e-05	0.000316	CcSEcCtD
Acebutolol—Dyspnoea—Capecitabine—prostate cancer	5.35e-05	0.000316	CcSEcCtD
Acebutolol—Oedema—Prednisone—prostate cancer	5.35e-05	0.000315	CcSEcCtD
Acebutolol—Fatigue—Docetaxel—prostate cancer	5.34e-05	0.000315	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—prostate cancer	5.34e-05	0.000315	CcSEcCtD
Acebutolol—Nausea—Mitoxantrone—prostate cancer	5.33e-05	0.000314	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—prostate cancer	5.3e-05	0.000313	CcSEcCtD
Acebutolol—Pain—Docetaxel—prostate cancer	5.3e-05	0.000313	CcSEcCtD
Acebutolol—Constipation—Docetaxel—prostate cancer	5.3e-05	0.000313	CcSEcCtD
Acebutolol—Dyspepsia—Capecitabine—prostate cancer	5.28e-05	0.000312	CcSEcCtD
Acebutolol—Chills—Epirubicin—prostate cancer	5.28e-05	0.000312	CcSEcCtD
Acebutolol—Pruritus—Etoposide—prostate cancer	5.28e-05	0.000311	CcSEcCtD
Acebutolol—Shock—Prednisone—prostate cancer	5.26e-05	0.00031	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—prostate cancer	5.25e-05	0.00031	CcSEcCtD
Acebutolol—Nervous system disorder—Prednisone—prostate cancer	5.24e-05	0.000309	CcSEcCtD
Acebutolol—Decreased appetite—Capecitabine—prostate cancer	5.22e-05	0.000308	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—prostate cancer	5.2e-05	0.000307	CcSEcCtD
Acebutolol—Skin disorder—Prednisone—prostate cancer	5.19e-05	0.000306	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Capecitabine—prostate cancer	5.18e-05	0.000306	CcSEcCtD
Acebutolol—Fatigue—Capecitabine—prostate cancer	5.17e-05	0.000305	CcSEcCtD
Acebutolol—Hyperhidrosis—Prednisone—prostate cancer	5.17e-05	0.000305	CcSEcCtD
Acebutolol—Constipation—Capecitabine—prostate cancer	5.13e-05	0.000303	CcSEcCtD
Acebutolol—Pain—Capecitabine—prostate cancer	5.13e-05	0.000303	CcSEcCtD
Acebutolol—Feeling abnormal—Docetaxel—prostate cancer	5.11e-05	0.000301	CcSEcCtD
Acebutolol—Diarrhoea—Etoposide—prostate cancer	5.1e-05	0.000301	CcSEcCtD
Acebutolol—Anorexia—Prednisone—prostate cancer	5.1e-05	0.000301	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—prostate cancer	5.08e-05	0.0003	CcSEcCtD
Acebutolol—Gastrointestinal pain—Docetaxel—prostate cancer	5.07e-05	0.000299	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—prostate cancer	5.05e-05	0.000298	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—prostate cancer	5.05e-05	0.000298	CcSEcCtD
Acebutolol—Back pain—Epirubicin—prostate cancer	4.96e-05	0.000292	CcSEcCtD
Acebutolol—Feeling abnormal—Capecitabine—prostate cancer	4.95e-05	0.000292	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—prostate cancer	4.94e-05	0.000292	CcSEcCtD
Acebutolol—Dizziness—Etoposide—prostate cancer	4.93e-05	0.000291	CcSEcCtD
Acebutolol—Gastrointestinal pain—Capecitabine—prostate cancer	4.91e-05	0.00029	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—prostate cancer	4.91e-05	0.00029	CcSEcCtD
Acebutolol—Body temperature increased—Docetaxel—prostate cancer	4.9e-05	0.000289	CcSEcCtD
Acebutolol—Abdominal pain—Docetaxel—prostate cancer	4.9e-05	0.000289	CcSEcCtD
Acebutolol—Chills—Doxorubicin—prostate cancer	4.89e-05	0.000288	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Prednisone—prostate cancer	4.87e-05	0.000287	CcSEcCtD
Acebutolol—Insomnia—Prednisone—prostate cancer	4.84e-05	0.000285	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—prostate cancer	4.83e-05	0.000285	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—prostate cancer	4.81e-05	0.000284	CcSEcCtD
Acebutolol—Paraesthesia—Prednisone—prostate cancer	4.8e-05	0.000283	CcSEcCtD
Acebutolol—Urticaria—Capecitabine—prostate cancer	4.77e-05	0.000281	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—prostate cancer	4.75e-05	0.00028	CcSEcCtD
Acebutolol—Abdominal pain—Capecitabine—prostate cancer	4.74e-05	0.00028	CcSEcCtD
Acebutolol—Body temperature increased—Capecitabine—prostate cancer	4.74e-05	0.00028	CcSEcCtD
Acebutolol—Vomiting—Etoposide—prostate cancer	4.74e-05	0.00028	CcSEcCtD
Acebutolol—Dyspepsia—Prednisone—prostate cancer	4.71e-05	0.000278	CcSEcCtD
Acebutolol—Rash—Etoposide—prostate cancer	4.7e-05	0.000278	CcSEcCtD
Acebutolol—Dermatitis—Etoposide—prostate cancer	4.7e-05	0.000277	CcSEcCtD
Acebutolol—Headache—Etoposide—prostate cancer	4.67e-05	0.000276	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—prostate cancer	4.67e-05	0.000276	CcSEcCtD
Acebutolol—Decreased appetite—Prednisone—prostate cancer	4.65e-05	0.000274	CcSEcCtD
Acebutolol—Malaise—Epirubicin—prostate cancer	4.62e-05	0.000273	CcSEcCtD
Acebutolol—Fatigue—Prednisone—prostate cancer	4.61e-05	0.000272	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—prostate cancer	4.6e-05	0.000272	CcSEcCtD
Acebutolol—Syncope—Epirubicin—prostate cancer	4.59e-05	0.000271	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—prostate cancer	4.59e-05	0.000271	CcSEcCtD
Acebutolol—Constipation—Prednisone—prostate cancer	4.57e-05	0.00027	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—prostate cancer	4.53e-05	0.000267	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—prostate cancer	4.5e-05	0.000266	CcSEcCtD
Acebutolol—Cough—Epirubicin—prostate cancer	4.47e-05	0.000264	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—prostate cancer	4.47e-05	0.000264	CcSEcCtD
Acebutolol—Asthenia—Docetaxel—prostate cancer	4.45e-05	0.000262	CcSEcCtD
Acebutolol—Nausea—Etoposide—prostate cancer	4.43e-05	0.000261	CcSEcCtD
Acebutolol—Feeling abnormal—Prednisone—prostate cancer	4.41e-05	0.00026	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—prostate cancer	4.4e-05	0.00026	CcSEcCtD
Acebutolol—Pruritus—Docetaxel—prostate cancer	4.39e-05	0.000259	CcSEcCtD
Acebutolol—Gastrointestinal pain—Prednisone—prostate cancer	4.37e-05	0.000258	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—prostate cancer	4.36e-05	0.000257	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—prostate cancer	4.36e-05	0.000257	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—prostate cancer	4.36e-05	0.000257	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—prostate cancer	4.35e-05	0.000256	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.33e-05	0.000256	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—prostate cancer	4.31e-05	0.000254	CcSEcCtD
Acebutolol—Asthenia—Capecitabine—prostate cancer	4.31e-05	0.000254	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—prostate cancer	4.28e-05	0.000252	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—prostate cancer	4.26e-05	0.000251	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—prostate cancer	4.25e-05	0.000251	CcSEcCtD
Acebutolol—Urticaria—Prednisone—prostate cancer	4.25e-05	0.000251	CcSEcCtD
Acebutolol—Pruritus—Capecitabine—prostate cancer	4.25e-05	0.000251	CcSEcCtD
Acebutolol—Diarrhoea—Docetaxel—prostate cancer	4.24e-05	0.00025	CcSEcCtD
Acebutolol—Abdominal pain—Prednisone—prostate cancer	4.23e-05	0.000249	CcSEcCtD
Acebutolol—Body temperature increased—Prednisone—prostate cancer	4.23e-05	0.000249	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—prostate cancer	4.22e-05	0.000249	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—prostate cancer	4.19e-05	0.000247	CcSEcCtD
Acebutolol—Oedema—Epirubicin—prostate cancer	4.18e-05	0.000247	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—prostate cancer	4.17e-05	0.000246	CcSEcCtD
Acebutolol—Cough—Doxorubicin—prostate cancer	4.14e-05	0.000244	CcSEcCtD
Acebutolol—Shock—Epirubicin—prostate cancer	4.11e-05	0.000243	CcSEcCtD
Acebutolol—Diarrhoea—Capecitabine—prostate cancer	4.11e-05	0.000242	CcSEcCtD
Acebutolol—Nervous system disorder—Epirubicin—prostate cancer	4.1e-05	0.000242	CcSEcCtD
Acebutolol—Dizziness—Docetaxel—prostate cancer	4.1e-05	0.000242	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—prostate cancer	4.06e-05	0.00024	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—prostate cancer	4.04e-05	0.000239	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—prostate cancer	4.04e-05	0.000238	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—prostate cancer	4.04e-05	0.000238	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—prostate cancer	4.04e-05	0.000238	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—prostate cancer	4.02e-05	0.000237	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.01e-05	0.000236	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—prostate cancer	3.99e-05	0.000235	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—prostate cancer	3.99e-05	0.000235	CcSEcCtD
Acebutolol—Dizziness—Capecitabine—prostate cancer	3.97e-05	0.000234	CcSEcCtD
Acebutolol—Vomiting—Docetaxel—prostate cancer	3.94e-05	0.000233	CcSEcCtD
Acebutolol—Rash—Docetaxel—prostate cancer	3.91e-05	0.000231	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—prostate cancer	3.91e-05	0.000231	CcSEcCtD
Acebutolol—Dermatitis—Docetaxel—prostate cancer	3.91e-05	0.00023	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—prostate cancer	3.9e-05	0.00023	CcSEcCtD
Acebutolol—Headache—Docetaxel—prostate cancer	3.88e-05	0.000229	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—prostate cancer	3.87e-05	0.000228	CcSEcCtD
Acebutolol—Asthenia—Prednisone—prostate cancer	3.84e-05	0.000226	CcSEcCtD
Acebutolol—Vomiting—Capecitabine—prostate cancer	3.82e-05	0.000225	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.81e-05	0.000225	CcSEcCtD
Acebutolol—Shock—Doxorubicin—prostate cancer	3.81e-05	0.000225	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—prostate cancer	3.79e-05	0.000224	CcSEcCtD
Acebutolol—Rash—Capecitabine—prostate cancer	3.78e-05	0.000223	CcSEcCtD
Acebutolol—Pruritus—Prednisone—prostate cancer	3.78e-05	0.000223	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—prostate cancer	3.78e-05	0.000223	CcSEcCtD
Acebutolol—Dermatitis—Capecitabine—prostate cancer	3.78e-05	0.000223	CcSEcCtD
Acebutolol—Headache—Capecitabine—prostate cancer	3.76e-05	0.000222	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—prostate cancer	3.76e-05	0.000222	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—prostate cancer	3.75e-05	0.000222	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—prostate cancer	3.74e-05	0.000221	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—prostate cancer	3.73e-05	0.00022	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—prostate cancer	3.72e-05	0.000219	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—prostate cancer	3.69e-05	0.000218	CcSEcCtD
Acebutolol—Nausea—Docetaxel—prostate cancer	3.68e-05	0.000217	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—prostate cancer	3.68e-05	0.000217	CcSEcCtD
Acebutolol—Diarrhoea—Prednisone—prostate cancer	3.66e-05	0.000216	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—prostate cancer	3.63e-05	0.000214	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—prostate cancer	3.62e-05	0.000213	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—prostate cancer	3.61e-05	0.000213	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—prostate cancer	3.61e-05	0.000213	CcSEcCtD
Acebutolol—Pain—Epirubicin—prostate cancer	3.58e-05	0.000211	CcSEcCtD
Acebutolol—Constipation—Epirubicin—prostate cancer	3.58e-05	0.000211	CcSEcCtD
Acebutolol—Nausea—Capecitabine—prostate cancer	3.57e-05	0.00021	CcSEcCtD
Acebutolol—Dizziness—Prednisone—prostate cancer	3.54e-05	0.000209	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.52e-05	0.000208	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—prostate cancer	3.5e-05	0.000206	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—prostate cancer	3.47e-05	0.000205	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—prostate cancer	3.45e-05	0.000204	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—prostate cancer	3.45e-05	0.000203	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—prostate cancer	3.44e-05	0.000203	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—prostate cancer	3.42e-05	0.000202	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—prostate cancer	3.41e-05	0.000201	CcSEcCtD
Acebutolol—Vomiting—Prednisone—prostate cancer	3.4e-05	0.000201	CcSEcCtD
Acebutolol—Rash—Prednisone—prostate cancer	3.37e-05	0.000199	CcSEcCtD
Acebutolol—Dermatitis—Prednisone—prostate cancer	3.37e-05	0.000199	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—prostate cancer	3.36e-05	0.000198	CcSEcCtD
Acebutolol—Headache—Prednisone—prostate cancer	3.35e-05	0.000198	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.34e-05	0.000197	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—prostate cancer	3.34e-05	0.000197	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—prostate cancer	3.32e-05	0.000196	CcSEcCtD
Acebutolol—Pain—Doxorubicin—prostate cancer	3.31e-05	0.000195	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—prostate cancer	3.31e-05	0.000195	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—prostate cancer	3.31e-05	0.000195	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—prostate cancer	3.31e-05	0.000195	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—prostate cancer	3.19e-05	0.000188	CcSEcCtD
Acebutolol—Nausea—Prednisone—prostate cancer	3.18e-05	0.000187	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—prostate cancer	3.16e-05	0.000187	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—prostate cancer	3.07e-05	0.000181	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—prostate cancer	3.06e-05	0.00018	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—prostate cancer	3.06e-05	0.00018	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—prostate cancer	3e-05	0.000177	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—prostate cancer	2.96e-05	0.000175	CcSEcCtD
Acebutolol—Diarrhoea—Epirubicin—prostate cancer	2.86e-05	0.000169	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—prostate cancer	2.78e-05	0.000164	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—prostate cancer	2.77e-05	0.000163	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—prostate cancer	2.74e-05	0.000162	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—prostate cancer	2.66e-05	0.000157	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—prostate cancer	2.65e-05	0.000156	CcSEcCtD
Acebutolol—Rash—Epirubicin—prostate cancer	2.64e-05	0.000156	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—prostate cancer	2.63e-05	0.000155	CcSEcCtD
Acebutolol—Headache—Epirubicin—prostate cancer	2.62e-05	0.000155	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—prostate cancer	2.56e-05	0.000151	CcSEcCtD
Acebutolol—Nausea—Epirubicin—prostate cancer	2.48e-05	0.000147	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—prostate cancer	2.46e-05	0.000145	CcSEcCtD
Acebutolol—Rash—Doxorubicin—prostate cancer	2.44e-05	0.000144	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—prostate cancer	2.44e-05	0.000144	CcSEcCtD
Acebutolol—Headache—Doxorubicin—prostate cancer	2.42e-05	0.000143	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—prostate cancer	2.3e-05	0.000136	CcSEcCtD
Acebutolol—ADRB1—Signaling Pathways—VAV3—prostate cancer	7.58e-06	0.000147	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MED12—prostate cancer	7.58e-06	0.000146	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GNG5—prostate cancer	7.52e-06	0.000145	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	7.5e-06	0.000145	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFBR2—prostate cancer	7.47e-06	0.000144	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	7.47e-06	0.000144	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC22A1—prostate cancer	7.45e-06	0.000144	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	7.42e-06	0.000143	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VAV3—prostate cancer	7.42e-06	0.000143	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TYMS—prostate cancer	7.37e-06	0.000142	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ITPR1—prostate cancer	7.35e-06	0.000142	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	7.31e-06	0.000141	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTM1—prostate cancer	7.28e-06	0.000141	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CB—prostate cancer	7.28e-06	0.000141	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SULT2A1—prostate cancer	7.26e-06	0.00014	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOA3—prostate cancer	7.24e-06	0.00014	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ITPR1—prostate cancer	7.19e-06	0.000139	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—LPL—prostate cancer	7.15e-06	0.000138	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MED12—prostate cancer	7.14e-06	0.000138	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	7.12e-06	0.000138	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GNG5—prostate cancer	7.09e-06	0.000137	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1R—prostate cancer	7.03e-06	0.000136	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL8—prostate cancer	7e-06	0.000135	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—JAK2—prostate cancer	6.96e-06	0.000135	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HPGDS—prostate cancer	6.91e-06	0.000134	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP1A1—prostate cancer	6.9e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1R—prostate cancer	6.88e-06	0.000133	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2C19—prostate cancer	6.87e-06	0.000133	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ERCC2—prostate cancer	6.85e-06	0.000132	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	6.85e-06	0.000132	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOA3—prostate cancer	6.83e-06	0.000132	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—JAK2—prostate cancer	6.81e-06	0.000132	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LPL—prostate cancer	6.74e-06	0.00013	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ACHE—prostate cancer	6.7e-06	0.00013	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTT1—prostate cancer	6.7e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2—prostate cancer	6.69e-06	0.000129	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PDGFRB—prostate cancer	6.68e-06	0.000129	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2A6—prostate cancer	6.63e-06	0.000128	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CB—prostate cancer	6.61e-06	0.000128	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LPL—prostate cancer	6.59e-06	0.000127	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2—prostate cancer	6.54e-06	0.000126	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	6.53e-06	0.000126	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HPGDS—prostate cancer	6.51e-06	0.000126	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ITGB3—prostate cancer	6.51e-06	0.000126	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	6.5e-06	0.000126	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2C19—prostate cancer	6.47e-06	0.000125	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	6.47e-06	0.000125	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKR1C3—prostate cancer	6.44e-06	0.000125	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—MTHFR—prostate cancer	6.44e-06	0.000124	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PRKACB—prostate cancer	6.41e-06	0.000124	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ITGB3—prostate cancer	6.37e-06	0.000123	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	6.36e-06	0.000123	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP17A1—prostate cancer	6.34e-06	0.000123	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTT1—prostate cancer	6.32e-06	0.000122	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ACHE—prostate cancer	6.32e-06	0.000122	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PPARA—prostate cancer	6.32e-06	0.000122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ERBB3—prostate cancer	6.31e-06	0.000122	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGFR2—prostate cancer	6.3e-06	0.000122	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.28e-06	0.000121	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2A6—prostate cancer	6.24e-06	0.000121	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	6.22e-06	0.00012	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ERBB3—prostate cancer	6.18e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGFR2—prostate cancer	6.17e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2—prostate cancer	6.07e-06	0.000117	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKR1C3—prostate cancer	6.07e-06	0.000117	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TERT—prostate cancer	6.05e-06	0.000117	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOA2—prostate cancer	6.05e-06	0.000117	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PRKACB—prostate cancer	6.04e-06	0.000117	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP17A1—prostate cancer	5.98e-06	0.000116	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2—prostate cancer	5.94e-06	0.000115	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CAV1—prostate cancer	5.94e-06	0.000115	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TERT—prostate cancer	5.92e-06	0.000114	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	5.79e-06	0.000112	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—SLC5A5—prostate cancer	5.77e-06	0.000111	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOA2—prostate cancer	5.7e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	5.66e-06	0.000109	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—LEP—prostate cancer	5.65e-06	0.000109	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2E1—prostate cancer	5.63e-06	0.000109	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CAV1—prostate cancer	5.6e-06	0.000108	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NQO1—prostate cancer	5.57e-06	0.000108	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KDR—prostate cancer	5.53e-06	0.000107	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—LEP—prostate cancer	5.53e-06	0.000107	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TH—prostate cancer	5.49e-06	0.000106	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CAV1—prostate cancer	5.48e-06	0.000106	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—SLC5A5—prostate cancer	5.43e-06	0.000105	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP3A4—prostate cancer	5.43e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KDR—prostate cancer	5.41e-06	0.000105	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CG—prostate cancer	5.41e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ESR1—prostate cancer	5.39e-06	0.000104	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP1B1—prostate cancer	5.34e-06	0.000103	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2E1—prostate cancer	5.31e-06	0.000103	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ESR1—prostate cancer	5.28e-06	0.000102	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BAD—prostate cancer	5.26e-06	0.000102	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NQO1—prostate cancer	5.25e-06	0.000101	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TH—prostate cancer	5.17e-06	0.0001	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GGT1—prostate cancer	5.17e-06	0.0001	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BAD—prostate cancer	5.15e-06	9.95e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—INS—prostate cancer	5.12e-06	9.89e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP3A4—prostate cancer	5.12e-06	9.89e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	5.1e-06	9.85e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APC—prostate cancer	5.1e-06	9.85e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOA1—prostate cancer	5.09e-06	9.85e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGF—prostate cancer	5.04e-06	9.74e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IRS1—prostate cancer	5.04e-06	9.74e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP1B1—prostate cancer	5.03e-06	9.73e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP19A1—prostate cancer	5.02e-06	9.7e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CREBBP—prostate cancer	5.01e-06	9.69e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	4.99e-06	9.64e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APC—prostate cancer	4.99e-06	9.64e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGF—prostate cancer	4.93e-06	9.53e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IRS1—prostate cancer	4.93e-06	9.53e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	4.89e-06	9.46e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GGT1—prostate cancer	4.87e-06	9.42e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—RXRA—prostate cancer	4.85e-06	9.37e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—INS—prostate cancer	4.83e-06	9.33e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOA1—prostate cancer	4.8e-06	9.28e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	4.79e-06	9.25e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CD—prostate cancer	4.75e-06	9.19e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP19A1—prostate cancer	4.73e-06	9.14e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	4.73e-06	9.14e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—INS—prostate cancer	4.72e-06	9.13e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1—prostate cancer	4.67e-06	9.02e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—COMT—prostate cancer	4.67e-06	9.02e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTP1—prostate cancer	4.65e-06	8.98e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	4.65e-06	8.98e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	4.62e-06	8.94e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ITPR1—prostate cancer	4.57e-06	8.83e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1—prostate cancer	4.57e-06	8.83e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—RXRA—prostate cancer	4.57e-06	8.83e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	4.54e-06	8.78e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	4.51e-06	8.72e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—NOS3—prostate cancer	4.49e-06	8.68e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	4.48e-06	8.66e-05	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	4.44e-06	8.58e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	4.43e-06	8.57e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	4.41e-06	8.53e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—COMT—prostate cancer	4.4e-06	8.5e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	4.39e-06	8.48e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	4.38e-06	8.47e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTP1—prostate cancer	4.38e-06	8.46e-05	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	4.34e-06	8.39e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	4.34e-06	8.38e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TYMS—prostate cancer	4.32e-06	8.35e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ITPR1—prostate cancer	4.31e-06	8.33e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	4.29e-06	8.3e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGF2—prostate cancer	4.29e-06	8.29e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTM1—prostate cancer	4.27e-06	8.25e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NOS3—prostate cancer	4.23e-06	8.18e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGF2—prostate cancer	4.2e-06	8.11e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—LPL—prostate cancer	4.19e-06	8.1e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CB—prostate cancer	4.14e-06	8.01e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NOS3—prostate cancer	4.14e-06	8e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JAK2—prostate cancer	4.11e-06	7.95e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—prostate cancer	4.11e-06	7.94e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TYMS—prostate cancer	4.07e-06	7.87e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP1A1—prostate cancer	4.05e-06	7.82e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	4.03e-06	7.79e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JAK2—prostate cancer	4.02e-06	7.78e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTM1—prostate cancer	4.02e-06	7.78e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MDM2—prostate cancer	4.02e-06	7.76e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ERCC2—prostate cancer	4.01e-06	7.76e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	3.96e-06	7.65e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—LPL—prostate cancer	3.95e-06	7.63e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	3.94e-06	7.62e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MDM2—prostate cancer	3.93e-06	7.59e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	3.91e-06	7.55e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	3.87e-06	7.48e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	3.82e-06	7.39e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.81e-06	7.37e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ERCC2—prostate cancer	3.78e-06	7.31e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—MTHFR—prostate cancer	3.77e-06	7.29e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	3.75e-06	7.26e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPARA—prostate cancer	3.7e-06	7.15e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	3.67e-06	7.1e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	3.67e-06	7.09e-05	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	3.63e-06	7.01e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—prostate cancer	3.59e-06	6.95e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2—prostate cancer	3.59e-06	6.93e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	3.59e-06	6.93e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTEN—prostate cancer	3.58e-06	6.92e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—prostate cancer	3.57e-06	6.9e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—MTHFR—prostate cancer	3.56e-06	6.87e-05	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	3.55e-06	6.86e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—prostate cancer	3.52e-06	6.79e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2—prostate cancer	3.51e-06	6.78e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCND1—prostate cancer	3.5e-06	6.76e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—prostate cancer	3.49e-06	6.75e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPARA—prostate cancer	3.49e-06	6.74e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CAV1—prostate cancer	3.48e-06	6.73e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	3.46e-06	6.69e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCND1—prostate cancer	3.42e-06	6.61e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—EP300—prostate cancer	3.42e-06	6.6e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—prostate cancer	3.4e-06	6.56e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	3.39e-06	6.55e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	3.38e-06	6.54e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTEN—prostate cancer	3.38e-06	6.52e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—prostate cancer	3.32e-06	6.42e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	3.31e-06	6.4e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTEN—prostate cancer	3.3e-06	6.38e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	3.29e-06	6.37e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CAV1—prostate cancer	3.28e-06	6.34e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	3.22e-06	6.23e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EP300—prostate cancer	3.22e-06	6.22e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CG—prostate cancer	3.17e-06	6.13e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EP300—prostate cancer	3.15e-06	6.09e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SRC—prostate cancer	3.13e-06	6.05e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SRC—prostate cancer	3.06e-06	5.92e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	3.05e-06	5.89e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—prostate cancer	3.02e-06	5.84e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—INS—prostate cancer	3e-06	5.8e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.99e-06	5.77e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	2.98e-06	5.77e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—prostate cancer	2.95e-06	5.71e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CREBBP—prostate cancer	2.94e-06	5.68e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—INS—prostate cancer	2.83e-06	5.47e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MYC—prostate cancer	2.81e-06	5.42e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	2.8e-06	5.41e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CD—prostate cancer	2.79e-06	5.39e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CREBBP—prostate cancer	2.77e-06	5.35e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MYC—prostate cancer	2.74e-06	5.3e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGFR—prostate cancer	2.74e-06	5.3e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	2.74e-06	5.29e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGFR—prostate cancer	2.68e-06	5.19e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NOS3—prostate cancer	2.63e-06	5.09e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.63e-06	5.08e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KRAS—prostate cancer	2.59e-06	5.01e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KRAS—prostate cancer	2.54e-06	4.9e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CA—prostate cancer	2.53e-06	4.88e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NOS3—prostate cancer	2.48e-06	4.79e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CB—prostate cancer	2.43e-06	4.69e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—prostate cancer	2.41e-06	4.65e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	2.38e-06	4.6e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	2.33e-06	4.5e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—prostate cancer	2.3e-06	4.45e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CB—prostate cancer	2.29e-06	4.42e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—prostate cancer	2.27e-06	4.38e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—prostate cancer	2.25e-06	4.36e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—prostate cancer	2.11e-06	4.08e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTEN—prostate cancer	2.1e-06	4.06e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—prostate cancer	2.06e-06	3.99e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—prostate cancer	2.06e-06	3.99e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—EP300—prostate cancer	2e-06	3.87e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTEN—prostate cancer	1.98e-06	3.82e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—prostate cancer	1.95e-06	3.76e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—prostate cancer	1.9e-06	3.68e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—EP300—prostate cancer	1.89e-06	3.65e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CA—prostate cancer	1.48e-06	2.86e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.4e-06	2.7e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—prostate cancer	1.21e-06	2.34e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—prostate cancer	1.14e-06	2.2e-05	CbGpPWpGaD
